TG and metastatic malignant neoplasm in the lymph nodes: Markers from the previously established model that still performed well were immunohistochemical Tg expression, high-risk histology (tall cell and hobnail variant PTC, DHGTC, and PDTC), and type of sample (primary tumor vs. lymph node metastasis).